Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Toward hepatitis C virus elimination using artificial intelligence

Moon Haeng Hur, Jeong-Hoon Lee

Clin Mol Hepatol. 2024;30(2):147-149. Published online February 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0135

View: 894 Download: 41 Crossref: 1

Original Article

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang

Clin Mol Hepatol. 2019;25(4):400-407. Published online May 28, 2019

DOI: https://doi.org/10.3350/cmh.2019.0006

View: 6063 Download: 125 Web of Science: 9 Crossref: 7

Review

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C

Seong Kyun Na, Byung-Cheol Song

Clin Mol Hepatol. 2019;25(3):234-244. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0108

View: 8024 Download: 245 Web of Science: 21 Crossref: 23

Original Article

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C

Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim

Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.272

View: 7260 Download: 38 Crossref: 1

The Korean Journal of Hepatology Elsewhere

Role of vitamin D in chronic hepatitis C

Tae Yeob Kim

Clin Mol Hepatol. 2011;17(2):170-172. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.170

View: 5293 Download: 39

Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin

Kyung-Ah Kim

Clin Mol Hepatol. 2011;17(1):84-86. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.84

View: 5367 Download: 37 Crossref: 1

3

Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b

Young-Joo Jin, M.D., Yoon Kyung Park, M.D., Gui Jun Yun, M.D. Han Chu Lee, M.D., Sook-Hyang Jeong, M.D. Gang Mo Kim, M.D., Young-Suk Lim, M.D., Young-Hwa Chung, M.D., Yung Sang Lee, M.D., Dong Jin Suh, M.D.

Clin Mol Hepatol. 2010;16(2):158-167. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.158

View: 4175 Download: 22

Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection

Myoung Joo Kang, M.D., Eun Uk Jung, M.D., Sang Won Park, M.D., Paul Choi, M.D., Ji Hyun Kim, M.D., Sung Jae Park, M.D., Eun Taek Park, M.D., Youn Jae Lee, M.D., Sang Hyuk Lee, M.D., Sang Yong Seol, M.D.

Clin Mol Hepatol. 2008;14(3):318-330. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.318

View: 5253 Download: 29 Crossref: 18

1 |

Viewed By 5241	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5172	MAFLD: How is it different from NAFLD?
Viewed By 5094	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3814	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3739	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search